Lv44
436 积分 2024-07-11 加入
Discovery of GTA182, a Novel CNS-Active Tricyclic Amide MTA-Cooperative PRMT5 Inhibitor for MTAP -Deleted Cancers
3小时前
已完结
Structurally Specific Z-DNA Proteolysis Targeting Chimera Enables Targeted Degradation of Adenosine Deaminase Acting on RNA 1
20天前
已完结
Abstract 4484: Discovery of a potential first-in-class Za targeted small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy
1个月前
已关闭
RIPTACs for Precision Cancer Therapy: A Novel Modality with the Inspiration of HLD-0915 as the First Candidate in Clinical Trials
1个月前
已完结
RIPTACs: A groundbreaking approach to drug discovery
1个月前
已完结
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
1个月前
已完结
RNA editing underlies genetic risk of common inflammatory diseases
1个月前
已完结
Targeting ADAR1 with a Novel Small-Molecule for the Treatment of Prostate Cancer
1个月前
已完结
The Carbene Chemistry of N-Sulfonyl Hydrazones: The Past, Present, and Future
2个月前
已完结
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
4个月前
已完结
皖公网安备34019202002308
